<code id='A78B7A6E03'></code><style id='A78B7A6E03'></style>
    • <acronym id='A78B7A6E03'></acronym>
      <center id='A78B7A6E03'><center id='A78B7A6E03'><tfoot id='A78B7A6E03'></tfoot></center><abbr id='A78B7A6E03'><dir id='A78B7A6E03'><tfoot id='A78B7A6E03'></tfoot><noframes id='A78B7A6E03'>

    • <optgroup id='A78B7A6E03'><strike id='A78B7A6E03'><sup id='A78B7A6E03'></sup></strike><code id='A78B7A6E03'></code></optgroup>
        1. <b id='A78B7A6E03'><label id='A78B7A6E03'><select id='A78B7A6E03'><dt id='A78B7A6E03'><span id='A78B7A6E03'></span></dt></select></label></b><u id='A78B7A6E03'></u>
          <i id='A78B7A6E03'><strike id='A78B7A6E03'><tt id='A78B7A6E03'><pre id='A78B7A6E03'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:7
          Cholesterol
          APStock

          Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

          Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed  reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

          advertisement

          The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          Discs beat pads, tampons for heavy menstrual flow, new study shows
          Discs beat pads, tampons for heavy menstrual flow, new study shows

          Menstrualdisc,reusablemenstrualeco-friendlyproduct.AdobeTherearemanyperiodproductsonthemarketfrompad

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Astronauts get first look at the spacecraft that will fly them around the moon

          ArtemisIIcrewmembers,fromleft,JeremyHansen,VictorGlover,ReidWisemanandChristinaKoch,standtogetheratN